H. Barr

677 total citations
25 papers, 430 citations indexed

About

H. Barr is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Speech and Hearing. According to data from OpenAlex, H. Barr has authored 25 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 4 papers in Speech and Hearing. Recurrent topics in H. Barr's work include Cystic Fibrosis Research Advances (20 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Bacterial biofilms and quorum sensing (7 papers). H. Barr is often cited by papers focused on Cystic Fibrosis Research Advances (20 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Bacterial biofilms and quorum sensing (7 papers). H. Barr collaborates with scholars based in United Kingdom, Germany and United States. H. Barr's co-authors include Andrew Fogarty, Alan R Smyth, John Britton, David A. Barrett, Miguel Cámara, Alan J. Knox, Paul Williams, Douglas L. Forrester, Stephen P. Diggle and Sophie E. Darch and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

H. Barr

23 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Barr United Kingdom 10 225 204 94 34 30 25 430
Anina Ratjen United States 7 175 0.8× 140 0.7× 96 1.0× 34 1.0× 22 0.7× 7 320
B. Tümmler Germany 10 182 0.8× 310 1.5× 50 0.5× 66 1.9× 17 0.6× 19 505
Clemente J. Britto United States 15 312 1.4× 313 1.5× 54 0.6× 38 1.1× 86 2.9× 30 797
Marie Dorda Germany 10 165 0.7× 194 1.0× 74 0.8× 27 0.8× 17 0.6× 18 334
Anna Tai Australia 11 134 0.6× 98 0.5× 75 0.8× 18 0.5× 35 1.2× 30 307
A Rüdeberg Switzerland 10 148 0.7× 623 3.1× 80 0.9× 30 0.9× 26 0.9× 18 852
R C Stern United States 8 151 0.7× 213 1.0× 67 0.7× 44 1.3× 14 0.5× 12 381
K Kanthakumar United States 9 88 0.4× 211 1.0× 20 0.2× 21 0.6× 23 0.8× 10 370
Celeste Barreto Portugal 16 174 0.8× 629 3.1× 22 0.2× 49 1.4× 6 0.2× 41 756
Simren K. Gill United Kingdom 8 126 0.6× 121 0.6× 20 0.2× 28 0.8× 45 1.5× 8 346

Countries citing papers authored by H. Barr

Since Specialization
Citations

This map shows the geographic impact of H. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Barr more than expected).

Fields of papers citing papers by H. Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Barr. The network helps show where H. Barr may publish in the future.

Co-authorship network of co-authors of H. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of H. Barr. A scholar is included among the top collaborators of H. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Barr. H. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ng, Christabella, Neele Dellschaft, Caroline L. Hoad, et al.. (2024). A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI). Journal of Cystic Fibrosis. 23(5). 984–990. 3 indexed citations
2.
Elliott, Zoe, Nicola J. Rowbotham, S.B. Carr, et al.. (2024). A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era. SHILAP Revista de lepidopterología. 3. 18–18.
3.
Sutharsan, Sivagurunathan, et al.. (2023). P117 A longitudinal study on the impact of elexacaftor/tezacaftor/ivacaftor treatment on quality of life in people with cystic fibrosis in the real world. Journal of Cystic Fibrosis. 22. S99–S100. 1 indexed citations
4.
Elliott, Zoe, Nicola J. Rowbotham, S.B. Carr, et al.. (2023). A grumbling concern: an international survey of gastrointestinal symptoms in cystic fibrosis in the modulator era. SHILAP Revista de lepidopterología. 3. 18–18. 7 indexed citations
5.
Zain, Nur Masirah M., Iain Stewart, Andrew Fogarty, et al.. (2022). Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis. Journal of Medical Microbiology. 71(2). 9 indexed citations
6.
Barr, H., et al.. (2022). A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021. Journal of Cystic Fibrosis. 21(2). 191–196. 4 indexed citations
7.
Dellschaft, Neele, Christabella Ng, Caroline L. Hoad, et al.. (2021). Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls. Journal of Cystic Fibrosis. 21(3). 502–505. 12 indexed citations
8.
Cámara, Miguel, Nur Masirah M. Zain, Nigel Halliday, et al.. (2021). Novel detection of specific bacterial quorum sensing molecules in saliva: Potential non-invasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis. Journal of Cystic Fibrosis. 21(4). 626–629. 7 indexed citations
9.
Webb, Kevin, Miguel Cámara, Nur Masirah M. Zain, et al.. (2021). 446: Novel detection of specific bacterial quorum-sensing molecules in saliva: Potential noninvasive biomarkers for pulmonary Pseudomonas aeruginosa in cystic fibrosis. Journal of Cystic Fibrosis. 20. S210–S211. 1 indexed citations
10.
Ng, Christabella, Neele Dellschaft, Caroline L. Hoad, et al.. (2020). Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging. Journal of Cystic Fibrosis. 20(4). 591–597. 26 indexed citations
11.
Barr, H., Miguel Cámara, David A. Barrett, et al.. (2017). Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis. ERJ Open Research. 3(3). 57–2017. 1 indexed citations
12.
Barr, H., Nigel Halliday, David A. Barrett, et al.. (2016). Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study. Journal of Cystic Fibrosis. 16(2). 230–238. 29 indexed citations
13.
Barr, H., Nigel Halliday, Miguel Cámara, et al.. (2015). Pseudomonas aeruginosaquorum sensing molecules correlate with clinical status in cystic fibrosis. European Respiratory Journal. 46(4). 1046–1054. 85 indexed citations
14.
Singh, Sonali, H. Barr, Yi‐Chia Liu, et al.. (2015). Granulocyte-Macrophage Colony Stimulatory Factor Enhances the Pro-Inflammatory Response of Interferon-γ-Treated Macrophages to Pseudomonas aeruginosa Infection. PLoS ONE. 10(2). e0117447–e0117447. 16 indexed citations
15.
Darch, Sophie E., Alan McNally, Freya Harrison, et al.. (2015). Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Scientific Reports. 5(1). 7649–7649. 95 indexed citations
16.
Baldwin, David, et al.. (2015). Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients. Metabolomics. 11(6). 1600–1611. 27 indexed citations
17.
Forrester, Douglas L., Alan J. Knox, Alan R Smyth, et al.. (2015). Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial. Pediatric Pulmonology. 51(3). 253–257. 5 indexed citations
18.
19.
Barr, H., John Britton, Alan R Smyth, & Andrew Fogarty. (2011). Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ. 343(aug23 1). d4662–d4662. 64 indexed citations
20.
Barr, H., et al.. (1986). Primary Small Bowel Ganglioneuroblastoma and Friedreich's Ataxia. Journal of the Royal Society of Medicine. 79(10). 612–613. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anina Ratjen Breakdown of academic impact, for papers by B. Tümmler Breakdown of academic impact, for papers by Clemente J. Britto Breakdown of academic impact, for papers by Marie Dorda Breakdown of academic impact, for papers by Anna Tai Breakdown of academic impact, for papers by A Rüdeberg Breakdown of academic impact, for papers by R C Stern Breakdown of academic impact, for papers by K Kanthakumar Breakdown of academic impact, for papers by Celeste Barreto Breakdown of academic impact, for papers by Simren K. Gill
Rankless by CCL
2026